161 related articles for article (PubMed ID: 36421918)
1. Activities and binding partners of E3 ubiquitin ligase DTX3L and its roles in cancer.
Vela-Rodríguez C; Lehtiö L
Biochem Soc Trans; 2022 Dec; 50(6):1683-1692. PubMed ID: 36421918
[TBL] [Abstract][Full Text] [Related]
2. Ubiquitin Modification by the E3 Ligase/ADP-Ribosyltransferase Dtx3L/Parp9.
Yang CS; Jividen K; Spencer A; Dworak N; Ni L; Oostdyk LT; Chatterjee M; Kuśmider B; Reon B; Parlak M; Gorbunova V; Abbas T; Jeffery E; Sherman NE; Paschal BM
Mol Cell; 2017 May; 66(4):503-516.e5. PubMed ID: 28525742
[TBL] [Abstract][Full Text] [Related]
3. Reconstitution of the DTX3L-PARP9 complex reveals determinants for high-affinity heterodimerization and multimeric assembly.
Ashok Y; Vela-Rodríguez C; Yang C; Alanen HI; Liu F; Paschal BM; Lehtiö L
Biochem J; 2022 Feb; 479(3):289-304. PubMed ID: 35037691
[TBL] [Abstract][Full Text] [Related]
4. Oligomerization mediated by the D2 domain of DTX3L is critical for DTX3L-PARP9 reading function of mono-ADP-ribosylated androgen receptor.
Vela-Rodríguez C; Yang C; Alanen HI; Eki R; Abbas TA; Maksimainen MM; Glumoff T; Duman R; Wagner A; Paschal BM; Lehtiö L
Protein Sci; 2024 Apr; 33(4):e4945. PubMed ID: 38511494
[TBL] [Abstract][Full Text] [Related]
5. Structural insights into ADP-ribosylation of ubiquitin by Deltex family E3 ubiquitin ligases.
Chatrin C; Gabrielsen M; Buetow L; Nakasone MA; Ahmed SF; Sumpton D; Sibbet GJ; Smith BO; Huang DT
Sci Adv; 2020 Sep; 6(38):. PubMed ID: 32948590
[TBL] [Abstract][Full Text] [Related]
6. Oligomerisation mediated by the D2 domain of DTX3L is critical for DTX3L-PARP9 reading function of mono-ADP-ribosylated androgen receptor.
Vela-Rodríguez C; Yang C; Alanen HI; Eki R; Abbas TA; Maksimainen MM; Glumoff T; Duman R; Wagner A; Paschal BM; Lehtiö L
bioRxiv; 2023 Nov; ():. PubMed ID: 38076829
[TBL] [Abstract][Full Text] [Related]
7. DTX3L and ARTD9 inhibit IRF1 expression and mediate in cooperation with ARTD8 survival and proliferation of metastatic prostate cancer cells.
Bachmann SB; Frommel SC; Camicia R; Winkler HC; Santoro R; Hassa PO
Mol Cancer; 2014 May; 13():125. PubMed ID: 24886089
[TBL] [Abstract][Full Text] [Related]
8. Synthetic Dual Cysteine-ADP Ribosylated Peptides from the Androgen Receptor are Recognized by the DTX3L/PARP9 Complex.
Wijngaarden S; Yang C; Vela-Rodríguez C; Lehtiö L; Overkleeft HS; Paschal BM; Filippov DV
ACS Chem Biol; 2023 Nov; 18(11):2377-2384. PubMed ID: 37939374
[TBL] [Abstract][Full Text] [Related]
9. KH-like Domains in PARP9/DTX3L and PARP14 Coordinate Protein-Protein Interactions to Promote Cancer Cell Survival.
Saleh H; Liloglou T; Rigden DJ; Parsons JL; Grundy GJ
J Mol Biol; 2024 Feb; 436(4):168434. PubMed ID: 38182103
[TBL] [Abstract][Full Text] [Related]
10. DELTEX2 C-terminal domain recognizes and recruits ADP-ribosylated proteins for ubiquitination.
Ahmed SF; Buetow L; Gabrielsen M; Lilla S; Chatrin C; Sibbet GJ; Zanivan S; Huang DT
Sci Adv; 2020 Aug; 6(34):. PubMed ID: 32937373
[TBL] [Abstract][Full Text] [Related]
11. Iduna is a poly(ADP-ribose) (PAR)-dependent E3 ubiquitin ligase that regulates DNA damage.
Kang HC; Lee YI; Shin JH; Andrabi SA; Chi Z; Gagné JP; Lee Y; Ko HS; Lee BD; Poirier GG; Dawson VL; Dawson TM
Proc Natl Acad Sci U S A; 2011 Aug; 108(34):14103-8. PubMed ID: 21825151
[TBL] [Abstract][Full Text] [Related]
12. DELTEX E3 ligases ubiquitylate ADP-ribosyl modification on nucleic acids.
Zhu K; Suskiewicz MJ; Chatrin C; Strømland Ø; Dorsey BW; Aucagne V; Ahel D; Ahel I
Nucleic Acids Res; 2024 Jan; 52(2):801-815. PubMed ID: 38000390
[TBL] [Abstract][Full Text] [Related]
13. Discovery of DTX3L inhibitors through a homogeneous FRET-based assay that monitors formation and removal of poly-ubiquitin chains.
Vela-Rodríguez C; Scarpulla I; Ashok Y; Lehtiö L
SLAS Discov; 2023 Dec; 28(8):365-375. PubMed ID: 37579950
[TBL] [Abstract][Full Text] [Related]
14. DTX3L Enhances Type I Interferon Antiviral Response by Promoting the Ubiquitination and Phosphorylation of TBK1.
Huang J; Chen Z; Ye Y; Shao Y; Zhu P; Li X; Ma Y; Xu F; Zhou J; Wu M; Gao X; Yang Y; Zhang J; Hao C
J Virol; 2023 Jun; 97(6):e0068723. PubMed ID: 37255478
[TBL] [Abstract][Full Text] [Related]
15. Mapping the interactome of HPV E6 and E7 oncoproteins with the ubiquitin-proteasome system.
Poirson J; Biquand E; Straub ML; Cassonnet P; Nominé Y; Jones L; van der Werf S; Travé G; Zanier K; Jacob Y; Demeret C; Masson M
FEBS J; 2017 Oct; 284(19):3171-3201. PubMed ID: 28786561
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitination independent of E1 and E2 enzymes by bacterial effectors.
Qiu J; Sheedlo MJ; Yu K; Tan Y; Nakayasu ES; Das C; Liu X; Luo ZQ
Nature; 2016 May; 533(7601):120-4. PubMed ID: 27049943
[TBL] [Abstract][Full Text] [Related]
17. Identification and Characterization of Physiological Pairing of E2 Ubiquitin-Conjugating Enzymes and E3 Ubiquitin Ligases.
Brillada C; Trujillo M
Methods Mol Biol; 2023; 2581():13-29. PubMed ID: 36413307
[TBL] [Abstract][Full Text] [Related]
18. NEDD8 and ubiquitin ligation by cullin-RING E3 ligases.
Baek K; Scott DC; Schulman BA
Curr Opin Struct Biol; 2021 Apr; 67():101-109. PubMed ID: 33160249
[TBL] [Abstract][Full Text] [Related]
19. Use of E2~ubiquitin conjugates for the characterization of ubiquitin transfer by RING E3 ligases such as the inhibitor of apoptosis proteins.
Middleton AJ; Budhidarmo R; Day CL
Methods Enzymol; 2014; 545():243-63. PubMed ID: 25065893
[TBL] [Abstract][Full Text] [Related]
20. Strategies to Trap Enzyme-Substrate Complexes that Mimic Michaelis Intermediates During E3-Mediated Ubiquitin-Like Protein Ligation.
Streich FC; Lima CD
Methods Mol Biol; 2018; 1844():169-196. PubMed ID: 30242710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
